it's number 4,$Amylyx Pharmaceuticals(AMLX.US)$all time low 6.5 USD... hope you can grow and get all FDA approval... it's profitable already... no 1.$渤健公司(BIIB.US)$all time low 2 USD no 2.$神經分泌生物科學(NBIX.US)$all time low 1.9 USD no 3.$Biohaven(BHVN.US)$all time low 7 USD no5.$argenx SE(ARGX.US)$all time low 17 USD And it's not bubble. Of course there are also, biotech companies which are failed. But I think if it's growing into a right directio...
$argenx SE(ARGX.US)$ Clinical Disappointment in Phase 3 Study: Pemphigus Vulgaris (PV) and Pemphigus Foliaceus (PF) Argenx's shares nosedived by 25% due to disappointing results from its Phase 3 study on efgartigimod subcutaneous (SC) for treating severe autoimmune diseases. The study aimed to address pemphigus vulgaris (PV) and pemphigus foliaceus (PF), causing skin blistering. Unexpectedly Strong Impact of Corticosteroids The primary setback was the ...
72840290 : 你不會抽太多嗎 @Nasser09
Jaguar8 72840290:
Jaguar8 72840290: 發現了嗎?
NASSER09樓主 72840290: 我有另一個應用程序